BRIEF—X-Chem and Almirall in drug discovery collaboration

Privately-held X-Chem and Spain's Almirall have agreed to enter into a drug discovery partnership looking for lead compounds in dermatology.

X-Chem will use its DNA-encoded library screening platform and informatics tools to search for novel hits for Almirall targets.

Almirall has the option to license drug leads, and will be responsible for further development and commercialization of the resulting programs.